Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice
Jacob S. Aday, Zachary Skiles, Noa Eaton, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 1, pp. 27-37
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement
Amy L. McGuire, I. Glenn Cohen, Dominic A. Sisti, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2414650-e2414650
Open Access | Times Cited: 11
Psychedelic-assisted psychotherapy: where is the psychotherapy research?
Jacob S. Aday, David Horton, Gisele Fernandes‐Osterhold, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1517-1526
Closed Access | Times Cited: 9
Informed Consent to Psychedelic Treatment—A Work in Progress
Paul S. Appelbaum
JAMA Psychiatry (2024) Vol. 81, Iss. 6, pp. 543-543
Closed Access | Times Cited: 5
Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?
Daniel Villiger
International Review of Psychiatry (2024), pp. 1-10
Open Access | Times Cited: 5
A Psilocybin Experience Gone Wrong: The Importance of Psychedelic Assisted Psychotherapy
Fernando Espí Forcén
Journal of Psychoactive Drugs (2025), pp. 1-3
Closed Access
Equipoise and Personal Experience: Maintaining Objectivity in Psychedelic Research
Katrina DeBonis, Walter Dunn, Thomas B. Strouse
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 74-76
Open Access
Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers
Kevin F. Boehnke, Kasey Cox, Cody Weston, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study
Charlie Song-Smith, Edward Jacobs, James Rucker, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e083595-e083595
Open Access | Times Cited: 4
Experiential Training in Psychedelic‐Assisted Therapy: A Risk‐Benefit Analysis
Daniel Rosenbaum, Crystal Hare, Emma Hapke, et al.
The Hastings Center Report (2024) Vol. 54, Iss. 4, pp. 32-46
Open Access | Times Cited: 4
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts
Ar Wilson-Poe, Ka Hoffman, Kellie Pertl, et al.
Journal of Psychoactive Drugs (2024), pp. 1-8
Closed Access | Times Cited: 4
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
David B. Yaden, Marianna Graziosi, Anna Owen, et al.
Psychedelic Medicine (2025)
Closed Access
Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic Use
Daniel J. Kruger, Janice K. Albrecht, Jacob S. Aday, et al.
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
EMBARK Psychedelic Therapy for Depression
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
Psychedelics in Psychiatry, the Nursing Influence, and the Future of Psychedelic Therapies
Carlton J. Spotswood
Journal of the American Psychiatric Nurses Association (2024)
Closed Access | Times Cited: 1
Is Personal Experience Essential for Effective Psychedelic Therapists?: The Challenges of Small, Accumulating Therapist Effects
Mitch Earleywine, Samantha G. Gomez
Psychedelic Medicine (2024) Vol. 2, Iss. 3, pp. 138-145
Closed Access | Times Cited: 1
Disability rights and experiential use of psychedelics in clinical research and practice
Maryam Golafshani, Daniel Z. Buchman, M. Ishrat Husain
npj Mental Health Research (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 1
Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States
Zachary Herrmann, Adam W. Levin, Steven P. Cole, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 3, pp. 139-149
Closed Access | Times Cited: 4
Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?
Antonio F. Pagán, Claudia Lex, Jair C. Soares, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 3, pp. 130-138
Closed Access | Times Cited: 3
The Elephant in the Room: Personal Use of Psychedelics Among Psychedelic Researchers
Peter S. Hendricks, Charles D. Nichols
Psychedelic Medicine (2023) Vol. 1, Iss. 3, pp. 122-123
Closed Access | Times Cited: 3
Psychedelic-assisted psychotherapy: Where is the psychotherapy research?
Jacob S. Aday, David P Horton, Gisele Fernandes‐Osterhold, et al.
(2023)
Open Access | Times Cited: 3
Introduction to the EMBARK Approach
Bill Brennan, Alex Belser
(2024), pp. 31-69
Closed Access
Preparation Sessions
Bill Brennan, Alex Belser
(2024), pp. 132-166
Closed Access
Bringing It Home and Carrying It Forward
Bill Brennan, Alex Belser
(2024), pp. 253-262
Closed Access
Considerations Prior to Meeting With a Participant
Bill Brennan, Alex Belser
(2024), pp. 93-131
Closed Access
INTRODUCTION: A New Approach for the Whole Person
Bill Brennan, Alex Belser
(2024), pp. 1-9
Closed Access
Page 1 - Next Page

Scroll to top